In the program, Vice President of JNKA, Mr. Takaoka explained the features of Nattokinase, including its ability to dissolve blood clots and the difference between natto and Nattokinase which does not contain vitamin K2 (warfarin users are restricted from taking Vitamin K2). 11 products with JNKA mark were also introduced.